Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Flexible budgeting adapts to life changes, helping you reallocate resources without derailing your overall plans and savings targets.
21,189 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Leveraged ETFs promise amplified moves, but they can amplify losses just as quickly. This guide breaks down why lever...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...
A new look at how digital money, especially stablecoins, is shaping illegal gold markets. Learn why stablecoins have ...
If you want steady income and long-term growth, these five dividend stocks right now combine durable dividends with s...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Insiders are quietly loading up on fintech stocks even as markets wobble. This article explains what those moves coul...
A 2025 NAHREP study finds Hispanic households added 441,000 owner-occupied homes, the largest annual gain on record, ...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
When a company in niche hardware makes a bold strategic move, the stock can leap. This piece explains how unusual mac...
A watershed moment hit crypto markets as bitcoin etfs shed $630m in one day. This article breaks down what drove the ...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...